Recent advances in clinical diagnosis and pharmacotherapy options of membranous nephropathy

HIGHLIGHTS

• who: GBM and collaborators from the Faculty of Life Science and Medicine, Northwest University, Xi`an, China, Key Disciplines of Clinical Pharmacy, Clinical Genetics have published the article: Recent Advances in Clinical Diagnosis and Pharmacotherapy Options of Membranous Nephropathy, in the Journal: (JOURNAL)
• how: Subsequent results showed that antibodies against PLA2R indeed were absent at disease the onset and could be detected during follow-up analysis (Ramachandran et_al 2015 van de Logt et_al 2015). The latest results indicated that remission at first 3 months were higher in the steroid-tacrolimus group than in the steroid . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.